ICU Medical EBITDA Margin 2010-2024 | ICUI
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for ICU Medical (ICUI) over the last 10 years. The current EBITDA margin for ICU Medical as of September 30, 2024 is .
| ICU Medical EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-09-30 | $2.34B | $0.22B | 9.57% |
| 2024-06-30 | $2.30B | $0.24B | 10.46% |
| 2024-03-31 | $2.26B | $0.24B | 10.59% |
| 2023-12-31 | $2.26B | $0.26B | 11.47% |
| 2023-09-30 | $2.25B | $0.27B | 12.18% |
| 2023-06-30 | $2.29B | $0.25B | 10.94% |
| 2023-03-31 | $2.31B | $0.26B | 11.45% |
| 2022-12-31 | $2.28B | $0.23B | 9.91% |
| 2022-09-30 | $2.04B | $0.21B | 10.33% |
| 2022-06-30 | $1.78B | $0.21B | 11.90% |
| 2022-03-31 | $1.54B | $0.19B | 12.32% |
| 2021-12-31 | $1.32B | $0.21B | 16.25% |
| 2021-09-30 | $1.30B | $0.22B | 16.67% |
| 2021-06-30 | $1.28B | $0.20B | 15.48% |
| 2021-03-31 | $1.26B | $0.19B | 14.76% |
| 2020-12-31 | $1.27B | $0.18B | 14.48% |
| 2020-09-30 | $1.27B | $0.17B | 13.18% |
| 2020-06-30 | $1.26B | $0.18B | 14.18% |
| 2020-03-31 | $1.26B | $0.18B | 14.56% |
| 2019-12-31 | $1.27B | $0.19B | 14.61% |
| 2019-09-30 | $1.29B | $0.16B | 12.71% |
| 2019-06-30 | $1.31B | $0.13B | 10.00% |
| 2019-03-31 | $1.36B | $0.13B | 9.65% |
| 2018-12-31 | $1.40B | $0.10B | 7.43% |
| 2018-09-30 | $1.43B | $0.16B | 10.92% |
| 2018-06-30 | $1.45B | $0.15B | 10.31% |
| 2018-03-31 | $1.42B | $0.08B | 5.79% |
| 2017-12-31 | $1.29B | $0.05B | 4.18% |
| 2017-09-30 | $1.02B | $0.01B | 0.98% |
| 2017-06-30 | $0.77B | $0.02B | 3.10% |
| 2017-03-31 | $0.54B | $0.07B | 12.83% |
| 2016-12-31 | $0.38B | $0.10B | 27.11% |
| 2016-09-30 | $0.37B | $0.10B | 27.27% |
| 2016-06-30 | $0.36B | $0.10B | 28.37% |
| 2016-03-31 | $0.35B | $0.10B | 28.86% |
| 2015-12-31 | $0.34B | $0.09B | 26.10% |
| 2015-09-30 | $0.33B | $0.09B | 26.59% |
| 2015-06-30 | $0.32B | $0.07B | 22.67% |
| 2015-03-31 | $0.32B | $0.06B | 19.56% |
| 2014-12-31 | $0.31B | $0.06B | 19.42% |
| 2014-09-30 | $0.31B | $0.06B | 20.20% |
| 2014-06-30 | $0.31B | $0.07B | 22.04% |
| 2014-03-31 | $0.31B | $0.07B | 22.68% |
| 2013-12-31 | $0.31B | $0.07B | 23.25% |
| 2013-09-30 | $0.32B | $0.08B | 24.45% |
| 2013-06-30 | $0.32B | $0.08B | 25.24% |
| 2013-03-31 | $0.32B | $0.08B | 26.35% |
| 2012-12-31 | $0.32B | $0.08B | 26.18% |
| 2012-09-30 | $0.31B | $0.09B | 29.03% |
| 2012-06-30 | $0.31B | $0.09B | 27.87% |
| 2012-03-31 | $0.31B | $0.09B | 27.78% |
| 2011-12-31 | $0.30B | $0.09B | 28.24% |
| 2011-09-30 | $0.30B | $0.07B | 24.41% |
| 2011-06-30 | $0.30B | $0.07B | 24.75% |
| 2011-03-31 | $0.29B | $0.07B | 24.48% |
| 2010-12-31 | $0.28B | $0.07B | 22.97% |
| 2010-09-30 | $0.28B | $0.06B | 21.74% |
| 2010-06-30 | $0.25B | $0.05B | 20.87% |
| 2010-03-31 | $0.24B | $0.05B | 21.43% |
| 2009-12-31 | $0.23B | $0.05B | 23.68% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $4.125B | $2.259B |
| ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $204.249B | 26.05 |
| Stryker (SYK) | United States | $146.711B | 33.06 |
| Boston Scientific (BSX) | United States | $132.644B | 38.14 |
| EssilorLuxottica (ESLOY) | France | $112.106B | 0.00 |
| Medtronic (MDT) | Ireland | $110.562B | 16.42 |
| Haleon (HLN) | United Kingdom | $43.682B | 28.38 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.166B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $37.665B | 19.54 |
| ResMed (RMD) | United States | $35.786B | 29.41 |
| Terumo (TRUMY) | Japan | $29.739B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $24.805B | 18.99 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.942B | 13.97 |
| Insulet (PODD) | United States | $18.443B | 73.44 |
| Baxter (BAX) | United States | $16.957B | 11.03 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.065B | 0.00 |
| BellRing Brands (BRBR) | United States | $10.158B | 40.72 |
| Bio-Rad Laboratories (BIO) | United States | $9.320B | 31.68 |
| Demant (WILYY) | Denmark | $8.342B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.294B | 14.62 |
| TG Therapeutics (TGTX) | United States | $5.459B | 0.00 |
| Haemonetics (HAE) | United States | $4.297B | 20.97 |
| Prestige Consumer Healthcare (PBH) | United States | $4.192B | 20.85 |
| Perrigo (PRGO) | Ireland | $3.830B | 11.27 |
| Envista Holdings (NVST) | United States | $3.697B | 27.54 |
| Neogen (NEOG) | United States | $3.246B | 37.45 |
| Agios Pharmaceuticals (AGIO) | United States | $3.175B | 0.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.841B | 18.22 |
| QuidelOrtho (QDEL) | United States | $2.700B | 17.38 |
| LeMaitre Vascular (LMAT) | United States | $2.428B | 59.00 |
| Warby Parker (WRBY) | United States | $2.349B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.913B | 33.48 |
| AtriCure (ATRC) | United States | $1.742B | 0.00 |
| InMode (INMD) | Israel | $1.597B | 9.61 |
| AdaptHealth (AHCO) | United States | $1.326B | 9.48 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.318B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.267B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.207B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.962B | 16.96 |
| Owens & Minor (OMI) | United States | $0.952B | 7.44 |
| CeriBell (CBLL) | United States | $0.943B | 0.00 |
| National Vision Holdings (EYE) | United States | $0.918B | 30.68 |
| Capricor Therapeutics (CAPR) | United States | $0.847B | 0.00 |
| Evolus (EOLS) | United States | $0.798B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.684B | 30.25 |
| Omeros (OMER) | United States | $0.632B | 0.00 |
| Surmodics (SRDX) | United States | $0.563B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.533B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.522B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.468B | 0.00 |
| Quanterix (QTRX) | United States | $0.451B | 0.00 |
| ZimVie (ZIMV) | United States | $0.391B | 32.95 |
| Valneva SE (VALN) | France | $0.360B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.341B | 32.41 |
| Cerus (CERS) | United States | $0.332B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.330B | 0.00 |
| Biote (BTMD) | United States | $0.325B | 7.12 |
| OraSure Technologies (OSUR) | United States | $0.289B | 19.40 |
| Zynex (ZYXI) | United States | $0.263B | 55.07 |
| Aurora Cannabis (ACB) | Canada | $0.238B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.225B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.221B | 15.29 |
| High Tide (HITI) | Canada | $0.213B | 88.33 |
| MacroGenics (MGNX) | United States | $0.203B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.188B | 2.64 |
| Brainsway (BWAY) | Israel | $0.167B | 100.00 |
| Organigram Holdings (OGI) | Canada | $0.166B | 0.00 |
| Jin Medical (ZJYL) | China | $0.164B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.160B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.149B | 18.67 |
| TriSalus Life Sciences (TLSI) | United States | $0.138B | 0.00 |
| Fonar (FONR) | United States | $0.104B | 11.74 |
| Quipt Home Medical (QIPT) | United States | $0.104B | 0.00 |
| Veru (VERU) | United States | $0.099B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 23.40 |
| Ayr Wellness (AYRWF) | United States | $0.077B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.073B | 37.50 |
| Exagen (XGN) | United States | $0.072B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.065B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| InterCure (INCR) | Israel | $0.062B | 0.00 |
| Modular Medical (MODD) | United States | $0.058B | 0.00 |
| MariMed (MRMD) | United States | $0.057B | 0.00 |
| Apyx Medical (APYX) | United States | $0.054B | 0.00 |
| Safety Shot (SHOT) | United States | $0.051B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.050B | 0.00 |
| ImmuCell (ICCC) | United States | $0.033B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.028B | 0.00 |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.018B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.016B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 12.83 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |